Abstract：Drug-induced nephrotoxicity in children is dependent upon the histological, anatomical and physiological features of their kidneys and the structural and functional characteristics of drugs. The kidney is mainly composed of microvascular network and tubulointerstitial tissue, so drug-induced nephrotoxicity is usually manifested by interstitial nephropathy. The mechanisms of drug-induced nephrotoxicity include cytotoxicity (necrosis or apoptosis), ischemic injury, and immunological injury. Individual drugs cause renal damage by various mechanisms due to differences in chemical structure and pharmacology. This article reviews the main features of nephrotoxicity induced by common antibiotics (cephalosporins, aminoglycosides, vancomycin, carbapenems and amphotericin B), non-steroidal anti-inflammatory drugs, and cyclosporine A.
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2): R31.
[2]
Basu RK, Wheeler DS. Approaches to the management of acute kidney injury in children[J]. Recent Pat Biomark, 2011, 1(1): 49-59.
[3]
Sekine T, Endou H. Children's toxicology from bench to bed-Drug-induced renal injury(3): Drug transporters and toxic nephropathy in childhood[J]. J Toxicol Sci, 2009, 34 Suppl 2: SP259-SP265.
[4]
Jennette JC, Olson JL, Schwartz MM, et al. Heptinstall's Pathology of the Kidney[M]. sixth edition, Lippincott Williams & Wilkins, 2007: 20.
[5]
Fanos V, Cataldi L. Renal transport of antibiotics and nephrotoxicity: a review[J]. J Chemother, 2001, 13: 461-742.
[6]
Kalghatgi S, Spina CS, Costello JC, et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells[J]. Sci Transl Med, 2013, 5(192): 192ra85.
[7]
Dagil R, O'Shea C, Nykjær A, et al. Gentamicin binds to the megalin receptor as a competitive inhibitor using the common ligand binding motif of complement type repeats: insight from the nmr structure of the 10th complement type repeat domain alone and in complex with gentamicin[J]. J Biol Chem, 2013, 288(6): 4424-4435.
[8]
Hazlewood KA, Brouse SD, Pitcher WD, et al. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?[J]. Am J Med, 2010, 123(2): 182.e1-e7.
[9]
Elyasi S, Khalili H, Dashti-Khavidaki S, et al. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations[J]. Eur J Clin Pharmacol, 2012, 68(9): 1243-1255.
[10]
Gupta A, Biyani M, Khaira A. Vancomycin nephrotoxicity: myths and facts[J]. Neth J Med, 2011, 69(9): 379-383.
[11]
Goa KL, Noble S. Panipenem/betamipron[J]. Drugs, 2003, 63(9): 913-925.
[12]
Tejedor A, Torres AM, Castilla M, et al. Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence[J]. Curr Med Res Opin, 2007, 23(3): 505-513.
[13]
Bagnis CI, Deray G. Amphotericin B nephrotoxicity[J]. Saudi J Kidney Dis Transpl, 2002, 13(4): 481-491.
[14]
Laniado-Laborin R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity[J]. Rev Iberoam Micol, 2009, 26(4): 223-227.
[15]
Chai LY, Netea MG, Tai BC, et al. An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity[J]. J Antimicrob Chemother, 2013, 68(7): 1655-1659.
[16]
Varlam DE, Siddiq MM, Parton LA, et al. Apoptosis contributes to amphotericin B-induced nephrotoxicity[J]. Antimicrob Agents Chemother, 2001, 45(3): 679-685.
[17]
Musu M, Finco G, Antonucci R, et al. Acute nephrotoxicity of NSAID from the foetus to the adult[J]. Eur Rev Med Pharmacol Sci, 2011, 15(12): 1461-1472.
[18]
Yoon HE, Yang CW. Established and newly proposed mechanisms of chronic cyclosporine nephropathy[J]. Korean J Intern Med, 2009, 24(2): 81-92.
[19]
Xiao Z, Shan J, Li C, et al. Mechanisms of cyclosporine-induced renal cell apoptosis: a systematic review[J]. Am J Nephrol, 2013, 37(1): 30-40.
[20]
Damiano S, Scanni R, Ciarcia R, et al. Regulation of sodium transporters in the kidney during cyclosporine treatment[J]. J Nephrol, 2010, 23 Suppl 16: S191-S198.
